IT1244529B - Peptidi sintetici atti a potenziare l'infettivita' del virus hiv-1 - Google Patents

Peptidi sintetici atti a potenziare l'infettivita' del virus hiv-1

Info

Publication number
IT1244529B
IT1244529B ITMI910220A ITMI910220A IT1244529B IT 1244529 B IT1244529 B IT 1244529B IT MI910220 A ITMI910220 A IT MI910220A IT MI910220 A ITMI910220 A IT MI910220A IT 1244529 B IT1244529 B IT 1244529B
Authority
IT
Italy
Prior art keywords
virus
hiv
infectivity
synthetic peptides
enhance
Prior art date
Application number
ITMI910220A
Other languages
English (en)
Inventor
Rossi Anita De
Marcella Pasti
Fabrizio Mammano
Marina Panozzo
Monica Dettin
Bello Carlo Di
Luigi Chieco-Bianchi
Original Assignee
Ist Superiore Sanita
Consiglio Nazionale Ricerche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ist Superiore Sanita, Consiglio Nazionale Ricerche filed Critical Ist Superiore Sanita
Publication of ITMI910220A0 publication Critical patent/ITMI910220A0/it
Priority to ITMI910220A priority Critical patent/IT1244529B/it
Priority to PCT/EP1992/000187 priority patent/WO1992013882A1/en
Priority to DE69202698T priority patent/DE69202698T2/de
Priority to JP4503252A priority patent/JPH06509637A/ja
Priority to AU11803/92A priority patent/AU1180392A/en
Priority to DK92903700.0T priority patent/DK0569428T3/da
Priority to AT92903700T priority patent/ATE123036T1/de
Priority to ES92903700T priority patent/ES2073287T3/es
Priority to EP92903700A priority patent/EP0569428B1/en
Publication of ITMI910220A1 publication Critical patent/ITMI910220A1/it
Priority to US08/097,751 priority patent/US5527666A/en
Application granted granted Critical
Publication of IT1244529B publication Critical patent/IT1244529B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/974—Aids related test

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Peptidi sintetici derivati dalla regione V3 del ceppo HTLV-1 B e del ceppo MN del virus HIV-1 atti a potenziare l'infettività del virus HIV-1 in colture cellulari in vitro e perciò utili nell'impiego per la determinazione dello stesso virus nel sangue ed in altri materiali biologici.
ITMI910220A 1991-01-30 1991-01-30 Peptidi sintetici atti a potenziare l'infettivita' del virus hiv-1 IT1244529B (it)

Priority Applications (10)

Application Number Priority Date Filing Date Title
ITMI910220A IT1244529B (it) 1991-01-30 1991-01-30 Peptidi sintetici atti a potenziare l'infettivita' del virus hiv-1
AU11803/92A AU1180392A (en) 1991-01-30 1992-01-29 Synthetic peptides suitable to enhance hiv-1 virus infectivity
DE69202698T DE69202698T2 (de) 1991-01-30 1992-01-29 Methode zur in vitro diagnose von hiv-1 virus infektionen.
JP4503252A JPH06509637A (ja) 1991-01-30 1992-01-29 Ｈｉｖ−１ウイルス感染性を高めるのに適した合成ペプチド
PCT/EP1992/000187 WO1992013882A1 (en) 1991-01-30 1992-01-29 Synthetic peptides suitable to enhance hiv-1 virus infectivity
DK92903700.0T DK0569428T3 (da) 1991-01-30 1992-01-29 Fremgangsmåde til diagnosticering in vitro af HIV-1-virusinfektioner
AT92903700T ATE123036T1 (de) 1991-01-30 1992-01-29 Methode zur in vitro diagnose von hiv-1 virus infektionen.
ES92903700T ES2073287T3 (es) 1991-01-30 1992-01-29 Metodo para el diagnostico in vitro de infecciones con virus hiv-1.
EP92903700A EP0569428B1 (en) 1991-01-30 1992-01-29 Method for the diagnosis in vitro of hiv-1 virus infections
US08/097,751 US5527666A (en) 1991-01-30 1993-07-23 Method for the diagnosis in vitro of HIV-1 virus infections

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI910220A IT1244529B (it) 1991-01-30 1991-01-30 Peptidi sintetici atti a potenziare l'infettivita' del virus hiv-1

Publications (3)

Publication Number Publication Date
ITMI910220A0 ITMI910220A0 (it) 1991-01-30
ITMI910220A1 ITMI910220A1 (it) 1992-07-30
IT1244529B true IT1244529B (it) 1994-07-15

Family

ID=11358323

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI910220A IT1244529B (it) 1991-01-30 1991-01-30 Peptidi sintetici atti a potenziare l'infettivita' del virus hiv-1

Country Status (10)

Country Link
US (1) US5527666A (it)
EP (1) EP0569428B1 (it)
JP (1) JPH06509637A (it)
AT (1) ATE123036T1 (it)
AU (1) AU1180392A (it)
DE (1) DE69202698T2 (it)
DK (1) DK0569428T3 (it)
ES (1) ES2073287T3 (it)
IT (1) IT1244529B (it)
WO (1) WO1992013882A1 (it)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2192937B1 (es) * 2001-05-29 2005-01-01 Universidad Miguel Hernandez De Elche Peptidos activadores de la infectividad del rhabdovirus de la septicemia hemorragica virica (vhsv).
JP6175055B2 (ja) * 2011-06-30 2017-08-02 ジェネトン ウイルス感染増強特性を有するペプチドおよびその使用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5017688A (en) * 1986-06-12 1991-05-21 Biogen, Inc. Peptides involved in the pathogenesis of HIV infection
EP0436634A1 (en) * 1988-10-03 1991-07-17 Repligen Corporation Hiv proteins and peptides useful in the diagnosis, prophylaxis or therapy of aids
PT94276A (pt) * 1989-06-05 1991-02-08 Anticorpo monoclonal capaz de neutralizar o prototipo mn de hiv

Also Published As

Publication number Publication date
ES2073287T3 (es) 1995-08-01
WO1992013882A1 (en) 1992-08-20
ITMI910220A0 (it) 1991-01-30
US5527666A (en) 1996-06-18
ATE123036T1 (de) 1995-06-15
EP0569428A1 (en) 1993-11-18
DE69202698D1 (de) 1995-06-29
DK0569428T3 (da) 1995-07-24
ITMI910220A1 (it) 1992-07-30
EP0569428B1 (en) 1995-05-24
DE69202698T2 (de) 1995-10-26
JPH06509637A (ja) 1994-10-27
AU1180392A (en) 1992-09-07

Similar Documents

Publication Publication Date Title
ES2104565T3 (es) Determinantes anti-receptor de celulas t como tratamiento de enfermedades autoinmunes.
ES2139574T3 (es) Nuevos gases propulsores y su uso en preparaciones medicas.
BR9709829A (pt) Formas de dosagem biconvexas de rápida desintegração
ES2157109T3 (es) Virus citopaticos para el tratamiento y la profilasis de la neoplasia.
DE69632256D1 (de) Antivirale proteine, dafür kodierende dna, und deren verwendung
ES2179040T3 (es) Utilizacion de 5-fluoro-2'-desoxi-3'-tiacitidina para el tratamiento de la hepatitis b.
MX9203439A (es) Una citocina mamifera, il-11
ES2182837T3 (es) Piran-2-onas y 5,6-dihidropiran-2-onas utiles en el tratamiento del sida y de otros retrovirus.
TR26888A (tr) Altin(1) merkapto karbonik asit esterleri
ES2151607T3 (es) Factor 12 de crecimiento y de diferenciacion.
DE69806900D1 (de) Polymerisierbare zementzusammensetzungen
ES2054353T3 (es) Expresion de las alipoproteinas humanas ai-milano en levadura.
DE59407457D1 (de) Blockierung der anlagerung von keimen an menschliche zellen
MX9702666A (es) Nuevos peptidos con efectos inmunoreguladores.
ES2074495T3 (es) Antitranspirante.
ATE107168T1 (de) Verwendung von gepiron zur herstellung eines pharmazeutischen präparats zur behandlung atypischer depression.
DE69013011D1 (de) Bcrf1-proteine als inhibitoren von interferon-g(g).
ES2082852T3 (es) Composicion liquida de prostaglandina.
ES2105605T3 (es) Antagonistas de taquiquinina, su preparacion y utilizacion en formulaciones farmaceuticas.
ES2080621T3 (es) Preparacion de uso cutaneo.
ES2049697T3 (es) Producto para el tratamiento del cabello y el cuerpo.
ES2137378T3 (es) Estructuras peptidicas poliramificadas para ser utilizadas contra el hiv.
ATE140389T1 (de) Hämoglobin-oligomer basierte komposition und seine herstellung
ES2078253T3 (es) Sintetasa de la sustancia ron biologicamente activa y su uso para producir sustancia ron biologicamente activa.
ITMI910220A1 (it) Peptidi sintetici atti a potenziare l'infettivita' del virus hiv-1

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19960130